相关实验视频

Updated: May 5, 2026

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

在随机临床试验中的代表性不足的群体中,HFrEF治疗效果的一致性

Guillaume Baudry^1,2, Luca Monzo¹, Mark C Petrie³

¹Université de Lorraine, Centre d'Investigations Cliniques Plurithématique, INSERM 1433, CHRU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Nancy, France.

NPJ cardiovascular health

|March 3, 2026

概括

在关键试验中,针对心力衰竭 (HF) 的指南导向医学疗法在不同人群中显示出一致的益处. 敦促进行更广泛的实施,并呼吁在未来开展更具包容性的研究,以确保健康公平.

科学领域:

心脏病学心脏病学
临床试验临床试验
健康公平卫生公平

背景情况:

指南导向医学疗法 (GDMT) 对心力衰竭 (HF) 有效.
在不同的人口群体中,GDMT的实施有很大的差异,包括种族和民族少数群体,老年人,女性和社会经济上处于贫困的个人.
了解不同人群中的治疗效应对于公平护理至关重要.

研究的目的:

审查与减少喷射率 (HFrEF) 的关键心力衰竭试验中的参与者代表性.
在HFrEF试验中分析医疗疗疗法的子组治疗效果.
倡导广泛的GDMT实施和更具包容性的研究.

主要方法:

在HFrEF中对关键临床试验进行系统审查.
在试验数据集中对参与者人口统计学的分析.
检查治疗疗效的子组分析.

主要成果:

关键的HFrEF试验往往缺乏充分的人口代表性.
医学疗法在代表的人口学子组中显示出大致一致的治疗效果.
证据支持GDMT在研究的不同人群中的有效性.

结论:

代表群体之间一致的疗效支持HFrEF疗法的广泛实施.
目前的试验数据倡导公平获得有效的HF治疗.
未来的HFrEF试验必须优先考虑多样性,以提高研究有效性和健康公平性.

更多相关视频

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

相关概念视频

Randomized Experiments

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...